Clinical epidemiology of cardiovascular disease in chronic kidney disease

K Kundhal1, C E Lok

  • 1University Health Network-Toronto General Hospital, University of Toronto, Toronto, Canada. charmaine.lok@uhn.on.ca

Insights

Cardiovascular disease (CVD) is the leading cause of death in chronic kidney disease (CKD) patients. This review examines CVD incidence, risk factors, outcomes, and CKD

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
  • Understanding CVD epidemiology in CKD is complex due to historical challenges in defining CKD and measuring renal function.
  • The interplay between renal impairment and cardiovascular disease, whether causal or consequential, remains a significant clinical question.

Purpose of the Study:

  • To review the current evidence on the incidence and prevalence of CVD in patients with chronic renal insufficiency and ESRD.
  • To identify and summarize risk factors associated with CVD in the CKD population.
  • To examine the outcomes for patients with renal failure who also have CVD, and to assess CKD's role as a CVD risk factor.

Main Methods:

  • Systematic review of existing epidemiological studies and clinical research.
  • Analysis of data on CVD incidence, prevalence, risk factors, and patient outcomes across all stages of CKD.
  • Evaluation of the literature concerning CKD as an independent risk factor for cardiovascular disease.

Main Results:

  • Epidemiological data reveal a substantial burden of CVD across all stages of CKD.
  • Specific risk factors for CVD in CKD patients are identified, contributing to poor outcomes.
  • CKD is confirmed as a significant risk factor for developing cardiovascular disease.

Conclusions:

  • The high prevalence of CVD in CKD underscores the urgent need for improved screening, diagnostic, and treatment strategies.
  • Further research is required to fully elucidate the complex relationship between kidney function and cardiovascular health.
  • Integrated approaches are necessary to manage cardiovascular risk in patients with chronic kidney disease.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...